Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
This piece explains why index fund performance changes over time and what factors investors should monitor for better outcomes.
27,966 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Insider trades can hint at a company's future, but not every move is meaningful. This article shows how to filter sig...
Rigetti Computing stock surged as government funding boosted optimism for quantum tech. Learn what happened, what it ...
This comprehensive guide breaks down Exzeo’s Q1 2026 results, reveals the drivers behind exzeo (xzo) 2026 earnings, a...
Forward Air’s path to 2025 earnings rests on freight demand, margins, and disciplined cost management. This guide bre...
This guide unpacks Granite Ridge earnings in plain terms. Learn the key metrics, what to listen for in the GRNT earni...
Visa is more than a brand name. This article explores whether could buying visa stock make sense for long-term wealth...
Costco stock has flashed sell-side headlines and uncertain momentum. This guide breaks down what a dip means for COST...
Pitney Bowes is navigating a pivot from legacy mailing services to software, data, and commerce solutions. This break...
Micron stock jumped today as traders weighed demand signals, supply dynamics, and broader market strength. This artic...
In March 2026, a disciplined approach to income investing means looking for companies with a proven track record of r...
As AI and cloud demand shape the tech landscape in early 2026, investors debate whether broad exposure through XLK or...